HER2 is not used in the LAB classification because it is commonly expressed by both luminal and MA tumours (our hypothesis is that HER2 promotes apocrine metaplasia of luminal cells, leading to a high frequency of HER2 amplification in the MA group). This evidence concerns the gene ERBB2 and neoplasm.